X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (213) 213
index medicus (205) 205
antibody-mediated rejection (176) 176
transplantation (141) 141
immunotherapy (134) 134
immunology (97) 97
surgery (86) 86
animals (74) 74
female (71) 71
graft rejection - immunology (68) 68
male (68) 68
kidney transplantation (66) 66
antibodies (64) 64
kidneys (56) 56
immunosuppression (52) 52
middle aged (51) 51
adult (46) 46
viral antibodies (45) 45
donor-specific antibodies (41) 41
analysis (37) 37
immunosuppressive agents - therapeutic use (36) 36
article (35) 35
graft rejection - prevention & control (35) 35
hla antibodies (34) 34
transplants & implants (34) 34
mice (33) 33
antibody‐mediated rejection (32) 32
health aspects (32) 32
graft rejection (31) 31
organ transplant recipients (31) 31
risk factors (31) 31
rituximab (31) 31
treatment outcome (30) 30
heart (29) 29
t cells (29) 29
oncology (28) 28
aged (27) 27
kidney-transplantation (27) 27
recipients (27) 27
rejection (27) 27
heart transplantation (26) 26
immunoglobulins (26) 26
prognosis (26) 26
immune response (24) 24
transplantation of organs, tissues, etc (24) 24
hla antigens - immunology (23) 23
kidney transplantation - adverse effects (23) 23
allograft-rejection (22) 22
b cells (22) 22
graft survival (22) 22
medicine, research & experimental (22) 22
survival (22) 22
histocompatibility antigens (21) 21
hla histocompatibility antigens (21) 21
antigens (20) 20
research (20) 20
adolescent (19) 19
international society (19) 19
intravenous immunoglobulin (19) 19
medical research (19) 19
regulatory t-cells (19) 19
renal-transplantation (19) 19
b-lymphocytes - immunology (18) 18
care and treatment (18) 18
graft rejection - etiology (18) 18
inflammation (18) 18
isoantibodies - immunology (18) 18
tolerance (18) 18
biopsy (17) 17
cancer (17) 17
dendritic cells (17) 17
follow-up studies (17) 17
graft survival - immunology (17) 17
histocompatibility testing (17) 17
humoral rejection (17) 17
immunosuppression - methods (17) 17
immunosuppressive agents (17) 17
infection (17) 17
medicine, experimental (17) 17
retrospective studies (17) 17
t-lymphocytes - immunology (17) 17
therapy (17) 17
tissue donors (17) 17
antibody-mediated immunotherapy (16) 16
antibody-mediated protection (16) 16
expression (16) 16
review (16) 16
alloantibody (15) 15
child (15) 15
graft rejection - diagnosis (15) 15
kidney transplantation - immunology (15) 15
plasmapheresis (15) 15
allografts (14) 14
antibodies, monoclonal - therapeutic use (14) 14
clinical trials (14) 14
diagnosis (14) 14
disease models, animal (14) 14
microbiology (14) 14
monoclonal antibodies (14) 14
proteins (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Microbiology and Infection, ISSN 1198-743X, 02/2012, Volume 18, Issue 2, pp. 126 - 133
Despite appropriate antifungal treatment, the management of cryptococcal disease remains challenging, especially in immunocompromised patients, such as human... 
Cryptococcus | interferon-γ | cytokines | HIV | immunotherapy | monoclonal antibodies | interferon‐γ | Monoclonal antibodies | Cytokines | Interferon-γ | Immunotherapy | INFECTIOUS DISEASES | FUNGICIDAL ACTIVITY | IFN-GAMMA | MICROBIOLOGY | NECROSIS-FACTOR-ALPHA | NEOFORMANS INFECTION | interferon | PERITONEAL-EXUDATE CELLS | PASSIVE-IMMUNIZATION | ANTIBODY-MEDIATED PROTECTION | INTERFERON-GAMMA | MONOCLONAL-ANTIBODIES | PULMONARY INFECTION | Cryptococcosis - therapy | Immunotherapy - methods | Animals | Cryptococcus - immunology | Humans | Cryptococcus - isolation & purification | Immunologic Factors - administration & dosage | Treatment Outcome | Immunocompromised Host | Antifungal Agents - administration & dosage | Disease Models, Animal | Analysis | Interferon alpha | Transplantation of organs, tissues, etc | Organ transplant recipients | HIV (Viruses) | Biological response modifiers | Health aspects | Interferon gamma | Infections | Drug therapy | Immune system | Animal models | Capsular polysaccharides | beta -Glucan | Immune response | Immunomodulation | Helper cells | Immunodeficiency | Data processing | Interleukin 23 | Inflammation | Interleukin 13 | Lymphocytes T | Interleukin 17 | Interleukin 18 | Infection | Glucuronoxylomannan | Interleukin 4 | Interleukin 10 | gamma -Interferon | Immunocompromised hosts | Melanin | Tumor necrosis factor- alpha
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2014, Volume 343, Issue 1, pp. 198 - 202
Journal Article
CNS and Neurological Disorders - Drug Targets, ISSN 1871-5273, 2009, Volume 8, Issue 1, pp. 31 - 49
There is substantial and compelling evidence that aggregation and accumulation of amyloid beta protein (A beta) plays a pivotal role in the development of... 
APP TRANSGENIC MICE | ADENOASSOCIATED VIRUS | ANTIBODY-MEDIATED CLEARANCE | DISEASE MOUSE MODEL | ALZHEIMERS-DISEASE | AMYLOID-BETA | DEPOSITION IN-VIVO | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | A-BETA-42 IMMUNIZATION | NEUROSCIENCES | PASSIVE-IMMUNIZATION
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 08/2014, Volume 343, Issue 1-2, pp. 198 - 202
Antibodies against LGI1 (leucin-rich glioma-inactivated 1 protein) are associated with limbic encephalitis (LE), which is characterized by a favorable outcome... 
LGI1 | Surface neuronal antibodies | Hyponatremia | Faciobrachial dystonic seizures | Limbic encephalitis | Antibody-mediated encephalitis | Encephalitis | Seizures (Medicine) | Gliomas | Immunotherapy
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 04/2019, Volume 15, Issue 4, pp. 876 - 890
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 09/2015, Volume 3, Issue 1, p. 41
Journal Article
Expert Review of Clinical Immunology, ISSN 1744-666X, 07/2019, Volume 15, Issue 7, pp. 701 - 706
Introduction: Pathogenic memory CD4 + T cells are the mainspring of autoimmune and allergic disorders, suggesting that effective pathogenetic immunotherapy... 
antibody-mediated cytotoxicity | allergy | pathogenic memory T cell | Therapeutic antibody | autoimmune disease | immune complex | COMPLEMENT | MEDIATED LYSIS | LEVEL | IMMUNOLOGY | CANCER | INFLAMMATION | THERAPIES
Journal Article
Current Pediatric Reviews, ISSN 1573-3963, 2009, Volume 5, Issue 2, pp. 112 - 117
Neuroblastoma is the third most common pediatric cancer in the United States and is responsible for 15% of pediatric cancer-related deaths. Despite major... 
Antibody-mediated therapy | Cell-mediated therapy | Cytokine-mediated therapy | Neuroblastoma | Immunotherapy
Journal Article